Neuromuscular Blockade: Difference between revisions

Neuromuscular Blockade (view source)

92 bytes added , 2 years ago

no edit summary

3,688

edits

Revision as of 16:22, 13 April 2022 (view source) WikiSysop (talk \| contribs) No edit summary ← Older edit		Revision as of 14:08, 19 August 2022 (view source) WikiSysop (talk \| contribs) No edit summary Newer edit →
Line 20:		Line 20:

	Saager L, Maiese EM, Bash LD, Meyer TA, Minkowitz H, Groudine S, Philip BK, Tanaka P, Gan TJ, Rodriguez-Blanco Y, Soto R, Heisel O. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study. J Clin Anesth 2019;55:33-41.		Saager L, Maiese EM, Bash LD, Meyer TA, Minkowitz H, Groudine S, Philip BK, Tanaka P, Gan TJ, Rodriguez-Blanco Y, Soto R, Heisel O. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study. J Clin Anesth 2019;55:33-41.

			[https://pubmed.ncbi.nlm.nih.gov/26646837/ Sugammadex and rocuronium-induced anaphylaxis]